Unknown

Dataset Information

0

Highly potent and selective ectonucleotide pyrophosphatase/phosphodiesterase I inhibitors based on an adenosine 5'-(? or ?)-thio-(?,?- or ?,?)-methylenetriphosphate scaffold.


ABSTRACT: Aberrant nucleotide pyrophosphatase/phosphodiesterase-1 (NPP1) activity is associated with chondrocalcinosis, osteoarthritis, and type 2 diabetes. The potential of NPP1 inhibitors as therapeutic agents, and the scarceness of their structure-activity relationship, encouraged us to develop new NPP1 inhibitors. Specifically, we synthesized ATP-?-thio-?,?-CH2 (1), ATP-?-thio-?,?-CCl2 (2), ATP-?-CH2-?-thio (3), and 8-SH-ATP (4) and established their resistance to hydrolysis by NPP1,3 and NTPDase1,2,3,8 (<5% hydrolysis) (NTPDase = ectonucleoside triphosphate diphosphohydrolase). Analogues 1-3 at 100 ?M inhibited thymidine 5'-monophosphate p-nitrophenyl ester hydrolysis by NPP1 and NPP3 by >90% and 23-43%, respectively, and only slightly affected (0-40%) hydrolysis of ATP by NTPDase1,2,3,8. Analogue 3 is the most potent NPP1 inhibitor currently known, Ki = 20 nM and IC50 = 0.39 ?M. Analogue 2a is a selective NPP1 inhibitor with Ki = 685 nM and IC50 = 0.57 ?M. Analogues 1-3 were found mostly to be nonagonists of P2Y1/P2Y2/P2Y11 receptors. Docking analogues 1-3 into the NPP1 model suggested that activity correlates with the number of H-bonds with binding site residues. In conclusion, we propose analogues 2a and 3 as highly promising NPP1 inhibitors.

SUBMITTER: Nadel Y 

PROVIDER: S-EPMC4363092 | biostudies-literature | 2014 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Highly potent and selective ectonucleotide pyrophosphatase/phosphodiesterase I inhibitors based on an adenosine 5'-(α or γ)-thio-(α,β- or β,γ)-methylenetriphosphate scaffold.

Nadel Yael Y   Lecka Joanna J   Gilad Yocheved Y   Ben-David Gal G   Förster Daniel D   Reiser Georg G   Kenigsberg Sarah S   Camden Jean J   Weisman Gary A GA   Senderowitz Hanoch H   Sévigny Jean J   Fischer Bilha B  

Journal of medicinal chemistry 20140530 11


Aberrant nucleotide pyrophosphatase/phosphodiesterase-1 (NPP1) activity is associated with chondrocalcinosis, osteoarthritis, and type 2 diabetes. The potential of NPP1 inhibitors as therapeutic agents, and the scarceness of their structure-activity relationship, encouraged us to develop new NPP1 inhibitors. Specifically, we synthesized ATP-α-thio-β,γ-CH2 (1), ATP-α-thio-β,γ-CCl2 (2), ATP-α-CH2-γ-thio (3), and 8-SH-ATP (4) and established their resistance to hydrolysis by NPP1,3 and NTPDase1,2,3  ...[more]

Similar Datasets

| S-EPMC10761680 | biostudies-literature
| S-EPMC3234731 | biostudies-literature
| S-EPMC9352230 | biostudies-literature
| S-EPMC6052110 | biostudies-literature
| S-EPMC5121889 | biostudies-literature
| S-EPMC6639061 | biostudies-literature
| S-EPMC10497752 | biostudies-literature
| S-EPMC5856437 | biostudies-literature
| S-EPMC6213977 | biostudies-literature
| S-EPMC9665351 | biostudies-literature